Leveraging AI to Address the Neuropsychiatric Conditions Associated with a Rare Disease

RARECast - Ein Podcast von RARECast - Donnerstags

Podimo 45 Tage kostenlos testen

Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

Werbung

Kategorien:

Wirtschaft

Neil Inala, CEO of Nobias Therapeutics, discusses how AI is transforming drug discovery, the data Nobias is able to use to fuel its drug discovery, and the company’s experimental therapy for the neuropsychiatric conditions associated with 22q11.2 deletion syndrome.

Visit the podcast's native language site